Sarah Hampl, part of the pediatric obesity program at Childrens Mercy Hospital in Kansas City, Missouri, told the Journal
In the ever-evolving world of weight management, few innovations have captured the public's imagination like GLP-1 receptor agonistsmedications such as semaglutide (found in Ozempic and Wegovy) and tirzepatide (Zepbound)
The study investigated the best concentration of DTNB by examining a range of concentrations from 100 to 5 mM, including 100, 500, 1, 2, 3, 4, and 5 mM
But Branded GLP-1s are so Expensive Lately, weve seen some our advocacy pay-off with Lilly and Novo both now offering direct to consumer pricing of around $500 per month but there is still more work to be done and OACs ultimate goals is to makes sure every insured person in the US has access to obesity medicines as a standard benefit covered by insurance (our advocacy on access is a fight we engage in everyday)